This setting of subjects exhibits an insulin-resistant status characterized by enhanced insulin production but reduced tissue sensitivity to hormone action, and 1-h-post-load hyperglycemia can be regarded as an early marker of IR (Marcovecchio et al., 2017). The gene discussed is INS; the disease is Hyperglycemia.